Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2019-09-30 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by Cellumed. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2019-09-30 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) for Cellumed Co., Ltd. It details the issuance of new shares, the purpose of the capital increase (facility and operating funds, acquisition of other companies' securities), the method (third-party allocation), and the board's resolution details. This falls under the category of announcements regarding new share issues and capital changes.
2019-09-18 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding the acquisition of shares in another corporation (타법인 주식 및 출자증권 양수결정). This type of regulatory filing details corporate transactions, M&A-related activities, and capital changes. Since it is a specific regulatory disclosure regarding a transaction (M&A/Investment) and does not fit into the other specific categories like 'TAR' (which is typically for takeover bids/mergers) or 'SHA' (which is for share issuance), it falls under the 'RNS' (Regulatory Filings) category as a standard regulatory disclosure for material corporate events.
2019-09-18 Korean
전환가액의조정(제21회차)
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price due to a decline in market price, which affects the company's capital structure and potential share dilution. This type of filing is categorized as a Capital/Financing Update (CAP) as it pertains to the terms of existing financing instruments.
2019-09-02 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Cellumed' (주식회사 셀루메드) for the period covering January 1, 2019, to June 30, 2019. It contains detailed company information, history, management changes, and financial reporting structures. In the context of Korean financial filings (DART), a '반기보고서' is a comprehensive interim report that includes financial statements and management analysis, which corresponds to the 'Interim / Quarterly Report' (IR) category. H1 2019
2019-08-14 Korean
증권발행결과(자율공시)(제23회차 CB)
Capital/Financing Update Classification · 1% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, specifically related to the issuance of new financial instruments.
2019-08-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.